These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 8218692)

  • 1. A 9-year follow-up study of the immunogenicity and long-term efficacy of plasma-derived hepatitis B vaccine in high-risk Chinese neonates.
    Ding L; Zhang M; Wang Y; Zhou S; Kong W; Smego RA
    Clin Infect Dis; 1993 Sep; 17(3):475-9. PubMed ID: 8218692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Persistence of protection against hepatitis B virus infection among adolescents vaccinated with recombinant hepatitis B vaccine beginning at birth: a 15-year follow-up study.
    Bialek SR; Bower WA; Novak R; Helgenberger L; Auerbach SB; Williams IT; Bell BP
    Pediatr Infect Dis J; 2008 Oct; 27(10):881-5. PubMed ID: 18756185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Long-term efficacy and persistence of Chinese infants after receiving only active plasma-derived hepatitis B vaccine].
    Xia G; Jia Z; Yan T; Li R; Liu H; Xu Z; Cao H; Liu C
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2002 Jun; 16(2):146-9. PubMed ID: 12196826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in response to a hepatitis B vaccine booster dose among Alaskan children and adolescents vaccinated during infancy.
    Samandari T; Fiore AE; Negus S; Williams JL; Kuhnert W; McMahon BJ; Bell BP
    Pediatrics; 2007 Aug; 120(2):e373-81. PubMed ID: 17636112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Twelve-year follow-up of a prospective randomized trial of hepatitis B recombinant DNA yeast vaccine versus plasma-derived vaccine without booster doses in children.
    Yuen MF; Lim WL; Cheng CC; Lam SK; Lai CL
    Hepatology; 1999 Mar; 29(3):924-7. PubMed ID: 10051499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Persistence of HB vaccine immune protection and response to hepatitis B booster immunization].
    Li H; Li R; Liao S; Yang J; Zeng X
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1998 Feb; 20(1):54-9. PubMed ID: 11367735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody levels and immune memory 23 years after primary plasma-derived hepatitis B vaccination: results of a randomized placebo-controlled trial cohort from China where endemicity is high.
    Wu Q; Zhuang GH; Wang XL; Wang LR; Li N; Zhang M
    Vaccine; 2011 Mar; 29(12):2302-7. PubMed ID: 21277403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody levels and protection after hepatitis B vaccine: results of a 22-year follow-up study and response to a booster dose.
    McMahon BJ; Dentinger CM; Bruden D; Zanis C; Peters H; Hurlburt D; Bulkow L; Fiore AE; Bell BP; Hennessy TW
    J Infect Dis; 2009 Nov; 200(9):1390-6. PubMed ID: 19785526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Studies on the status of immune memory after completion of hepatitis B vaccination].
    Li YP; Li RC; Fang KX; Li HM; Hu ZY; He P; Wu XY; Zhang R; Liang ZL; Zhuang H
    Zhonghua Liu Xing Bing Xue Za Zhi; 2007 Apr; 28(4):319-21. PubMed ID: 17850693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Long-term efficacy of plasma-derived hepatitis B vaccine among Chinese children--a 12-year follow-up].
    Liao S; Li R; Li H; Yang J; Zeng X
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1998 Apr; 20(2):89-94. PubMed ID: 11367725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Observation on effects of hepatitis B vaccine immunization for 12 years in children in Beijing].
    Gong XH; Wang FZ; Li H; Liu LR; Li YH; Wang BL; Li LQ; Zhang Z; Han QY; Tang YW
    Zhonghua Yu Fang Yi Xue Za Zhi; 2005 Jul; 39(4):265-8. PubMed ID: 16194384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis B immunity in children vaccinated with recombinant hepatitis B vaccine beginning at birth: a follow-up study at 15 years.
    Hammitt LL; Hennessy TW; Fiore AE; Zanis C; Hummel KB; Dunaway E; Bulkow L; McMahon BJ
    Vaccine; 2007 Sep; 25(39-40):6958-64. PubMed ID: 17714836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evaluation of the effectiveness nine years after primary immunization with local produced plasma-derived hepatitis B vaccine].
    Xu H; Zuo H; Zhuang G
    Zhonghua Yu Fang Yi Xue Za Zhi; 1998 Jul; 32(4):205-7. PubMed ID: 10322755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Waning immunity to plasma-derived hepatitis B vaccine and the need for boosters 15 years after neonatal vaccination.
    Lu CY; Chiang BL; Chi WK; Chang MH; Ni YH; Hsu HM; Twu SJ; Su IJ; Huang LM; Lee CY
    Hepatology; 2004 Dec; 40(6):1415-20. PubMed ID: 15565627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-titer antibody to hepatitis B surface antigen before liver transplantation can prevent de novo hepatitis B infection.
    Su WJ; Ho MC; Ni YH; Chen HL; Hu RH; Wu YM; Chang MH; Lee PH
    J Pediatr Gastroenterol Nutr; 2009 Feb; 48(2):203-8. PubMed ID: 19179883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Long-term efficacy study of hepatitis B vaccination in newborns--results of 11 years' follow-up].
    Lin X; Xu Z; Ou-Yang P
    Zhonghua Liu Xing Bing Xue Za Zhi; 1999 Jun; 20(3):174-7. PubMed ID: 10682531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis B vaccination in high-risk infants: 10-year follow-up.
    Wu JS; Hwang LY; Goodman KJ; Beasley RP
    J Infect Dis; 1999 Jun; 179(6):1319-25. PubMed ID: 10228050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Long-term efficacy of vaccination against hepatitis B in newborns: 13 years' follow-up].
    Wu W; Sun C; Jiang M; Xu Y; Zhang GH; Liu CB; Cao HL; Lin XM; Xu ZY
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2001 Sep; 15(3):239-41. PubMed ID: 11986695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Follow-up on hepatitis B immunized neonates born to HBsAg positive mothers].
    Zhang X; Xing Y; Shen L
    Zhonghua Yu Fang Yi Xue Za Zhi; 1998 Mar; 32(2):97-9. PubMed ID: 10322808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long term antibody response to hepatitis B vaccination beginning at birth and to subsequent booster vaccination.
    Williams IT; Goldstein ST; Tufa J; Tauillii S; Margolis HS; Mahoney FJ
    Pediatr Infect Dis J; 2003 Feb; 22(2):157-63. PubMed ID: 12586980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.